RxDoctor Payments Data

Aaron Frodsham, MD

Vascular & Interventional Radiology · Salt Lake City, UTNPI 1184807208

Payments from drug & device makers

What this record shows

This record is dominated by other: $87,833 of the $103,159 with a category attached, or 85.1%. Angiodynamics, Inc. accounts for 91.8% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $31,972 and has fallen 58.8% since, to $13,175 in 2025. Among vascular & interventional radiology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$103,159in general payments, 2019–2025

Across 187 payments — averaging $551.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$95K
  • Philips North America LLC$2K
  • Boston Scientific$1K
  • SPR Therapeutics, Inc$1K
  • Bard Peripheral Vascular, Inc.$779
  • Sirtex Medical Inc$575
  • plus $3K from 20 others

What the payments were for

  • Travel & lodging$2,1302%
  • Food & beverage$6,4886%
  • Education$6,7087%
  • Other$87,83385%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$103,159 in reported general payments places this provider in the 90th percentile of 38 vascular & interventional radiology providers in Utah.

See all vascular & interventional radiology providers in Utah

Medicare billing

Part B allowed, 2024
$547,007
Medicare patients
113
Services billed
3,296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$18,881
Cilostazol35$983
ClopidogrelClopidogrel Bisulfate121$827
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$261

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →